Insider Transactions in Q2 2023 at Ekso Bionics Holdings, Inc. (EKSO)
Insider Transaction List (Q2 2023)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jun 12
2023
|
Jerome Wong Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Indirect |
8,200
+41.81%
|
-
|
Jun 12
2023
|
Jerome Wong Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
170,068
+38.51%
|
-
|
Jun 12
2023
|
Jason C Jones Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Indirect |
10,800
+41.39%
|
-
|
Jun 12
2023
|
Jason C Jones Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
190,454
+22.66%
|
-
|
Jun 08
2023
|
Mary Ann Cloyd Director |
BUY
Grant, award, or other acquisition
|
Direct |
72,993
+33.05%
|
-
|
Jun 08
2023
|
Kecheng Li Director |
BUY
Grant, award, or other acquisition
|
Direct |
72,993
+32.42%
|
-
|
Jun 08
2023
|
Rhonda A. Wallen Director |
BUY
Grant, award, or other acquisition
|
Direct |
72,993
+33.05%
|
-
|
Jun 08
2023
|
Corinna Lathan Director |
BUY
Grant, award, or other acquisition
|
Direct |
72,993
+34.29%
|
-
|
Jun 08
2023
|
Steven Sherman Executive Chair |
BUY
Grant, award, or other acquisition
|
Direct |
91,241
+16.67%
|
-
|
May 24
2023
|
Steven Sherman Executive Chair |
SELL
Open market or private sale
|
Direct |
45,660
-11.12%
|
$45,660
$1.44 P/Share
|
May 08
2023
|
Jason C Jones Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
3,435
-2.42%
|
$3,435
$1.57 P/Share
|